Alcidion GroupASX:ALC +10.53%50 EBIT per Share is A$0.00 as of Dec. 2025. GuruFocus rates ASX:ALC with a GF Score™ of 50/100 and a GF Value™ of A$0.12 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 530 Healthcare Providers & Services companies, Alcidion Group ranks worse than 98.49% on this metric.
Alcidion Group's EBIT per Share for the
six
months ended in Dec. 2025 was A$0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00.
During the past 3 years, the average EBIT per Share Growth Rate was -91.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Alcidion Group's EBIT per Share or its related term are showing as below:
ASX:ALC'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -91.3 Med: 0 Max: 62.1
Current: -91.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Alcidion Group was 62.10% per year. The lowest was -91.30% per year. And the median was 0.00% per year.
ASX:ALC's 3-Year EBIT Growth Rate is ranked worse than 98.49% of 530
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs ASX:ALC: -91.30
Alcidion Group's EBIT for the
six
months ended in Dec. 2025 was A$1.59 Mil.
Alcidion Group (ASX:ALC) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Alcidion Group EBIT per Share Related Terms
Alcidion Group EBIT per Share Historical Data
* Premium members only.
The historical data trend for Alcidion Group's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcidion Group (ASX:ALC) has a EBIT per Share of A$0.00 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Alcidion Group and its competitors. According to the industry distribution chart, Alcidion Group ranks #522 out of 530 companies in the Healthcare Providers & Services industry, placing it in the top 98.5%.
Is Alcidion Group's EBIT per Share too high?
Alcidion Group's current EBIT per Share is A$0.00. Based on the distribution chart, Alcidion Group ranks #522 out of 530 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Alcidion Group has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcidion Group's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #522 out of 530 companies for EBIT per Share. This places Alcidion Group in the lower half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 530 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current EBIT per Share is A$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.11 — trading 12.5% below its estimated fair value. The current EBIT per Share is A$0.00. Alcidion Group's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current EBIT per Share is A$0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alcidion Group (ASX:ALC) Overvalued in 2026?
Based on GuruFocus' analysis, Alcidion Group stock appears to be undervalued.
The current stock price of A$0.11 is trading 12.5% below its estimated GF Value™ of A$0.12.
GuruFocus considers Alcidion Group to be Modestly Undervalued.
Key valuation signals for ASX:ALC:
EBIT per Share: A$0.00
GF Value™: A$0.12 vs. price of A$0.11 (12.5% below fair value)
No single metric tells the full story. See the ASX:ALC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
50GF Score
Get the complete analysis for ASX:ALC
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 
